Inflammatory microenvironment in both healthy controls and ARDS patients polarize clinically utilized MSCs towards a pro-inflammatory MSC phenotype

S. Rolandsson Enes (Lund, Sweden), T. H. Hampton (Hanover, United States of America), D. H. Mckenna (Minnesota, United States of America), C. C. Dos Santos (Toronto, Canada), K. D. Liu (San Francisco, United States of America), B. A. Stanton (Hanover, United States of America), P. R. M. Rocco (Rio de Janeiro, Brazil), M. A. Matthay (San Francisco, United States of America), D. J. Weiss (Burlington, United States of America)

Source: Virtual Congress 2020 – Cellular involvement in lung injury
Session: Cellular involvement in lung injury
Session type: Oral Presentation
Number: 4473

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Rolandsson Enes (Lund, Sweden), T. H. Hampton (Hanover, United States of America), D. H. Mckenna (Minnesota, United States of America), C. C. Dos Santos (Toronto, Canada), K. D. Liu (San Francisco, United States of America), B. A. Stanton (Hanover, United States of America), P. R. M. Rocco (Rio de Janeiro, Brazil), M. A. Matthay (San Francisco, United States of America), D. J. Weiss (Burlington, United States of America). Inflammatory microenvironment in both healthy controls and ARDS patients polarize clinically utilized MSCs towards a pro-inflammatory MSC phenotype. 4473

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Monocytes and dendritic cells with hyperinflammatory profile in lungs of sarcoidosis patients
Source: International Congress 2018 – Granulomatous disorders: heterogeneous diseases with variable management
Year: 2018

Dynamic of proinflammatory cytokines system and nonspecific markers of inflammation in patients with COPD before and after treatment with broncholitics
Source: Eur Respir J 2006; 28: Suppl. 50, 38s
Year: 2006

The expression of TSLP in monocyte derived dendritic cells in the interactions between respiratory epithelium and macrophages in asthma, COPD and healthy controls
Source: International Congress 2019 – Novel insights from in vitro and in vivo models of lung disease
Year: 2019


Airway fibroblasts phenotype markers after pro-inflammatory cytokines challenge
Source: Annual Congress 2009 - Novel mechanisms in the pathogenesis of asthma
Year: 2009


Functional comparison of bone-marrow derived mesenchymal stromal cells obtained from COPD patients and non-COPD controls
Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema
Year: 2015


Pro-inflammatory stimuli affect the production of cytokines and growth factors by human bone marrow-derived mesenchymal stem cells
Source: Annual Congress 2008 - Inflammatory trigger mechanisms in asthma and COPD
Year: 2008


Nintedanib inhibits pro-fibrotic mediators from T cells with relevance to connective tissue disease-associated interstitial lung disease
Source: International Congress 2017 – Lung fibrosis: basic science
Year: 2017

Mesenchymal stromal cells (MSC) anti-microbial effect in acute respiratory distress syndrome (ARDS) is mediated in part by enhanced alveolar macrophage phagocytosis through cell contact-dependent mitochondrial transfer leading to improved macrophage bioenergetics
Source: International Congress 2016 – Novel insights into alveolar and bronchial epithelial cell injury and repair
Year: 2016


Circulating MDSC modulate IPF progression by orchestrating immunosuppressive and pro-fibrotic networks
Source: International Congress 2018 – Advanced profiling of immune cells in chronic lung diseases
Year: 2018

Different expression of pro- and antiinflammatory cytokines in chlamydia pneumoniae infected blood monocytes and alveolar macrophages from COPD patients and healthy volunteers
Source: Eur Respir J 2002; 20: Suppl. 38, 220s
Year: 2002

Small airway fibroblasts from COPD patients are senescent and pro-fibrotic
Source: International Congress 2018 – New kids on the block: novel molecular pathways and therapeutic targets in chronic lung diseases
Year: 2018



COPD monocytes differentiate into pro-inflammatory macrophages regardless of environment
Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection
Year: 2013

MSC extracellular vesicles modulate human macrophages in ARDS towards anti-inflammatory phenotype via transfer of miRNA181-a and PTEN-pSTAT5-SOCS1 signalling
Source: Virtual Congress 2021 – Cellular and molecular involvement in lung injury and repair
Year: 2021



Extracellular Hsp70 modulates inflammatory response in PBEC cells from COPD patients
Source: International Congress 2018 – COPD: immune regulation and therapeutic targets
Year: 2018


GM-CSF and CSF-1 co-regulate lung inflammation and ERMP12+ progenitor recruitment during immune responses to LPS in vivo
Source: Eur Respir J 2006; 28: Suppl. 50, 300s
Year: 2006

Chemokines induced in human lung epithelial cells by inflammatory cytokines
Source: Eur Respir J 2006; 28: Suppl. 50, 748s
Year: 2006

Tim-3 regulates Tregs’ ability to resolve the inflammation and proliferation of acute lung injury by polarizing M2c macrophages
Source: International Congress 2017 – Anti-inflammatory and pro-repair mediators in acute lung injury
Year: 2017

Pulmonary inflammatory cells strongly express IL-18 in asthma death cases
Source: Annual Congress 2008 - Understanding the mechanisms and the impact of severe asthma
Year: 2008


Dendritic cells (DC) and expression of Th1 and Th2-attractant chemokines in the airways of asthmatics and controls
Source: Annual Congress 2009 - Inflammatory cells and cytokines
Year: 2009

Immunotherapeutic strategy with mesenchymal stem cells modulating inflammation in an experimental model of COPD.
Source: Virtual Congress 2020 – New insight into the immunology of asthma and COPD
Year: 2020